Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape 
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 13.87 +0.03 (0.22%)
Previous Close $13.84    52 Week High $3.65 
Open $13.92    52 Week Low $1.24 
Day High $13.95    P/E N/A 
Day Low $13.72    EPS $0.00 
Volume 24,336